The Ticker: EZchip CEO Defends Valuation Assigned to the Company in Mellanox Merger

Clal Biotech, Access invest $10 million in U.S. cancer-therapy startup; Tel Aviv shares start quarter with a yawn.

new-hdc-logo
Haaretz
Send in e-mailSend in e-mail
Eli Fruchter, president and CEO of EZchip.Credit: Hagay Frid

Comments